Cargando…
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance
Malaria continues to exact a great human toll in tropical settings. Antimalarial resistance is rife and the parasite inexorably develops mechanisms to outwit our best drugs, including the now first-line choice, artesunate. Novel strategies to circumvent resistance are needed. Here we detail drug dev...
Autores principales: | Shahinas, Dea, Folefoc, Asongna, Pillai, Dylan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235713/ https://www.ncbi.nlm.nih.gov/pubmed/25436880 http://dx.doi.org/10.3390/pathogens2010033 |
Ejemplares similares
-
A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)
por: Shahinas, Dea, et al.
Publicado: (2013) -
Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009–2013)
por: Mohon, Abu Naser, et al.
Publicado: (2014) -
Mutations in P. falciparum K13 propeller gene from Bangladesh: emerging resistance?
por: Alam, Mohammed Shafiul, et al.
Publicado: (2014) -
Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future
por: Stofberg, Melissa Louise, et al.
Publicado: (2021) -
Artesunate Misuse and Plasmodium falciparum Malaria in Traveler Returning from Africa
por: Shahinas, Dea, et al.
Publicado: (2010)